↓ Skip to main content

High expression of Lewisy/bantigens is associated with decreased survival in lymph node negative breast carcinomas

Overview of attention for article published in Breast Cancer Research, July 2005
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)

Mentioned by

patent
5 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
70 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
High expression of Lewisy/bantigens is associated with decreased survival in lymph node negative breast carcinomas
Published in
Breast Cancer Research, July 2005
DOI 10.1186/bcr1305
Pubmed ID
Authors

Zahra Madjd, Tina Parsons, Nicholas FS Watson, Ian Spendlove, Ian Ellis, Lindy G Durrant

Abstract

There is sufficient evidence that blood group related Lewis antigens are tumour-associated molecules. The Lewisy and Lewisb antigens are complex carbohydrates that are over-expressed by breast, lung, colon and ovarian cancers. The SC101 mAb is a unique Lewisy/b binding antibody that binds to native and extended Lewisy and Lewisb haptens, displaying no cross reactivity with H type 1, H type 2, Lewisx or normal blood group antigens.

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Argentina 1 3%
Unknown 35 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 39%
Student > Ph. D. Student 7 19%
Student > Bachelor 4 11%
Student > Master 3 8%
Student > Doctoral Student 2 6%
Other 0 0%
Unknown 6 17%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 14 39%
Agricultural and Biological Sciences 5 14%
Chemistry 5 14%
Medicine and Dentistry 5 14%
Mathematics 1 3%
Other 0 0%
Unknown 6 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2021.
All research outputs
#3,857,751
of 19,047,010 outputs
Outputs from Breast Cancer Research
#522
of 1,771 outputs
Outputs of similar age
#61,758
of 307,415 outputs
Outputs of similar age from Breast Cancer Research
#1
of 1 outputs
Altmetric has tracked 19,047,010 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,771 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,415 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them